Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02524418 · ClinicalTrials.gov registry record · NA
Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT02524418: Completed NA study, sponsored by University of Florida.
NCT02524418 is a NA study that has completed, run by University of Florida. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02524418, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
This is a prospective evaluation of the clinical utility of the new cholangioscopy platform SpyGlass DS. The aims of this study are to prospectively document the clinical utility and technical aspects of ERCP with cholangioscopy and/or pancreatoscopy in the diagnosis and management of pancreatic-biliary disorders.
Primary Outcome
The performance of the Spyglass DS during the endoscopy will be based on the ability to reach the target site, obtain samples, and to deliver therapeutic intervention.
Interventions
- PROCEDURE Cholangiopancreatoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT02524418 record still lists
NCT02524418 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Cholangiopancreatoscopy is the first listed.
NCT02524418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02524418 about?
NCT02524418 is a clinical study titled "Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS". This is a prospective evaluation of the clinical utility of the new cholangioscopy platform SpyGlass DS. The aims of this study are to prospectively document the clinical utility and technical aspects of ERCP with cholangioscopy and/or pancreatoscopy in the diagnosis and management of pancreatic-bil...
What is the current status of trial NCT02524418?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2015-08. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02524418?
The interventions under investigation include: Cholangiopancreatoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02524418?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02524418's enrollment target sits among peer trials
88 972nd of 2000 higher than 1,027 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia